Refine your search
149 trials found
Recruiting
Not yet recruiting
Recruiting
NCT06462235
A Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Hospitals With Bacterial Infection (CHERISH)
Gram-negative Bacterial Infection
Male or Female
Up to 39 weeks
19study location(s)
Recruiting
NCT06760637
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
Breast Cancer
Male or Female
18+ years
255study location(s)
Recruiting
NCT06629779
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Metastatic Castration-Resistant Prostate Cancer
Males
18+ years
186study location(s)
Recruiting
NCT05253651
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Colorectal Neoplasms
Male or Female
18+ years
389study location(s)
Recruiting
NCT06977581
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Asthma
Male or Female
18 - 70 years
16study location(s)
Recruiting
NCT06758401
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
Male or Female
18+ years
7study location(s)
Recruiting
NCT04649242
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Pediatric Migraine
Male or Female
6 - 17 years
228study location(s)
Recruiting
NCT06215118
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)
Multiple Myeloma
Male or Female
18+ years
34study location(s)
Recruiting
NCT05355701
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Melanoma, Non-Small-Cell Lung Cancer, Thyroid Cancer, Glioma
Male or Female
16+ years
38study location(s)
Recruiting
NCT05070845
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
Primary Immune Thrombocytopenia
Male or Female
18 - 70 years
26study location(s)
Saved trials
Saved trials
You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.
Recruiting
Not yet recruiting
Contact us
For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.